Nuzenio

Tipranks Analyst Reiterates

Tipranks Analyst Reiterates entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 24 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Analyst Reiterates Buy on Costco, Citing Durable Growth and Membership Strength; Price Target Maintained at $1,194 - TipRanksTipRanks · Sun, 09 Aug 2026 01:05:55 GMTAnalyst Thomas Fitzgerald Lifts Target Price to C$29 and Reiterates Buy Rating on Resilient Canadian Travel Demand and Margin Expansion Outlook into 2027 - TipRanksTipRanks · Sat, 08 Aug 2026 11:24:24 GMTAnalyst Reiterates Buy on AC Immune as 2H26 Catalysts Approach; Price Target Maintained at $12 - TipRanksTipRanks · Sat, 08 Aug 2026 00:45:00 GMTAnalyst Reiterates Buy on EZCORP After Strong Quarter, Keeps $44 Price Target Unchanged - TipRanksTipRanks · Sat, 08 Aug 2026 00:00:04 GMTAnalyst Reiterates Buy on LYEL, Sees Upside From Ronde-cel Leadership With Price Target Maintained at $45 - TipRanksTipRanks · Fri, 07 Aug 2026 23:08:40 GMTAnalyst Reiterates Sell on Doximity Amid AI Investment Headwinds and Margin Pressure; $20 Price Target Unchanged - TipRanksTipRanks · Fri, 07 Aug 2026 15:41:42 GMTAnalyst Reiterates Buy on Prothena, Citing Disciplined Capital Strategy and Undervalued TTR Franchise with Unchanged $30 Price Target - TipRanksTipRanks · Fri, 07 Aug 2026 15:11:37 GMTAnalyst Roger Boyd Reiterates Buy on Gen Digital, Sets $36 Price Target on Strong Growth, Guidance Raise and Attractive Valuation - TipRanksTipRanks · Fri, 07 Aug 2026 14:03:02 GMT

Timeline

Sun, 09 Aug 2026 01:05:55 GMTAnalyst Reiterates Buy on Costco, Citing Durable Growth and Membership Strength; Price Target Maintained at $1,194 - TipRanks
Sat, 08 Aug 2026 11:24:24 GMTAnalyst Thomas Fitzgerald Lifts Target Price to C$29 and Reiterates Buy Rating on Resilient Canadian Travel Demand and Margin Expansion Outlook into 2027 - TipRanks
Sat, 08 Aug 2026 00:45:00 GMTAnalyst Reiterates Buy on AC Immune as 2H26 Catalysts Approach; Price Target Maintained at $12 - TipRanks
Sat, 08 Aug 2026 00:00:04 GMTAnalyst Reiterates Buy on EZCORP After Strong Quarter, Keeps $44 Price Target Unchanged - TipRanks
Fri, 07 Aug 2026 23:08:40 GMTAnalyst Reiterates Buy on LYEL, Sees Upside From Ronde-cel Leadership With Price Target Maintained at $45 - TipRanks
Fri, 07 Aug 2026 15:41:42 GMTAnalyst Reiterates Sell on Doximity Amid AI Investment Headwinds and Margin Pressure; $20 Price Target Unchanged - TipRanks

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.EconomyEconomy stories explain how money, jobs, prices, policy, trade, and business confidence affect daily life.AIAI stories cover models, chips, safety, regulation, products, jobs, research, and how automated systems are being used.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Analyst Reiterates.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.